Lurasidone Effects on Tissue Glutamate in Schizophrenia
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
24 individuals with schizophrenia or schizoaffective disorders, who are currently considered
stable, will be recruited, screened for entry criteria into a blinded study with a 4-week
randomization to either lurasidone, haloperidol, or perphenazine to examine glutamate-related
outcomes with lurasidone as compared to haloperidol and perphenazine.